SCHEMBL7477339

SCHEMBL7477339

CN(Cc1ccc(Cl)cc1)C(=O)c1n[nH]c2c(C#CC(O)c3ccccc3)cc(CC3CCOCC3)cc2c1=O

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.35
HAT1 O14929 1/20 0.31
EP300 Q09472 1/20 0.31
NPC1 O15118 1/20 0.31
HSP90AA1 P07900 1/20 0.31
PIN1 Q13526 1/20 0.31
P2RX7 Q99572 1/20 0.31
TP53 P04637 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
PDE4B Q07343 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6668749 0.90 NR1H4 (0.36) NR1H4NPC1HSP90AA1PIN1P2RX7
SCHEMBL6672672 0.88 NR1H4 (0.34) NR1H4NPC1HSP90AA1P2RX7
SCHEMBL6672237 0.86 NR1H4 (0.33) NR1H4HSP90AA1P2RX7
SCHEMBL6666111 0.83 NR1H4 (0.37) NR1H4NPC1HSP90AA1PIN1P2RX7
SCHEMBL6667531 0.79 NR1H4 (0.34) NR1H4NPC1HSP90AA1P2RX7
SCHEMBL6672234 0.78 NR1H4 (0.34) NR1H4NPC1HSP90AA1P2RX7
SCHEMBL7482403 0.78 NR1H4 (0.34) NR1H4NPC1HSP90AA1P2RX7
SCHEMBL7472513 0.76 AKR1C3 (0.36) NR1H4NPC1
SCHEMBL6668075 0.75 ABCB1 (0.38) ALDH1A1
SCHEMBL6668752 0.74 RAB9A (0.44) HAT1EP300NPC1TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265873-A2 4-OXO-1,4-DIHYDRO-3-CINNOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2002-12-18 EP disclosed
WO-2001070706-A2 4-OXO-1,4-DIHYDRO-3-CINNOLINECARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2001-09-27 WO disclosed